It was established in the year of 1971, named as Kun-Ann county-pharmaceutical factory, Hubei province. And then was acquired and merged by the now current parent company, I-Tsai-Lin bio-agricultural company, in the year of December 2003. From then, rebuild the factory on the current address with brand new modern facility. Obtained the national GMP validation with formal certification by the year of December 2004. as major and-qualified suppliers on bulk pharmaceuticals, various extracts on Traditional Chinese herbs as well, the superior formulation products, it supplies need of both domestic and foreign customers with sound satisfaction.

Currently, Jin-Hai Pharmaceutical occupied an area 66670 square meters in this site and with three buildings totally a space of 8,000 square meters for organic synthesis, extraction facilities and formulation production purpose. In addition to office building, it also with an up to date research laboratory- collaborates quality control, quality assurance capacity and capability to secure the product standard strictly according to GMP requirements.

At present, this Company accomplished seven production lines that including synthetic drugs, phytochemical extraction, solid phase fermentation, and formulation that including tablets, capsules, powder forms. The annually capacity with 10 tons of synthetic drugs, 600 tons of extracts, as well as one billion counts of formulation products.

From the vertical integration and horizontal expansion, Jin Hai is now forging into a traditional Chinese medicine system that starts from raw plant into extraction and formulation.

This company is focusing on modernization of traditional Chinese medicine, such as new formulations, new products, and creating the advantages form the effective combinations of raw material, processing medicines including 22 different finish products, and more than 40 Chinese raw drugs with good quality and availabilities.
Jin Hai Pharmaceutical with up to date equipments, unyielding on site management, advance quality assurance and practice, also quantity production capacity make it is a good supplier with super competitive edge due to tight control the cost and effective production.

This Company understands the quality starts from the control of raw herbs; hence, it builds the green production bases with GAP standard and practice in order to secure the quality of herbs use in its production.

For the extraction of herbs, this company is work with new sciences and technologies in this regard. Such as application of finger printing, carbon dioxide super critical extraction, static extraction, double effect extraction, and also use ethanol as solvent extraction. We aim for reproducibility of standardization of extracts and finish products, all the practice is under proven standard operational procedure with maximize auto-production equipments and methods. This company is with the doctrine and mission to produce all the products with safe, effective, stable, and reproducible.

Jin Hai Pharmaceuticals understands that the experts and talents are the vital part of its life for newer research and development. The research and development center with high quality personnel including post-graduated trained professional with many with Ph. D. degrees from both domestic and aboard. It is the first training center of pharmaceutical industry for post-doctorate talents. With this as base, this Company has long term cooperative relationship with many academic institutions including esteemed Tong Chi Medical University, Hubei college of Traditional Chinese Medicine, and universities in Hunan.

Continuous research and development makes Jin Hai also into the latest advance is to step into the wanted generic drug area. Since Jin Hai has good control of the key intermediate, MPA(mycophenolic acid), production and procurement, this company is now step into the well known immuno-depresant drug, mycophenolate motefil (MMF), for the organ transplant patients and for the auto-immune diseases. Jin Hai is the first one able to produce bulk drug in China and first one to cooperate with health care institution to study the bio-availability and bioequalvence.

The market coverage of Jin Hai pharmaceuticals now is over thirty provinces inside country, and also exports the products to Southeast Asia, Southern America, African countries and with more than 200 satisfied customers around the world.